John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 17,628 shares at $2.12 ($37K) on 2023-12-20, disclosed to the SEC on 2023-12-21.
Open-market sale of $37k VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |